PerspectiveCANCER

Priming Cancer Cells for Death

See allHide authors and affiliations

Science  25 Nov 2011:
Vol. 334, Issue 6059, pp. 1075-1076
DOI: 10.1126/science.1215568

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

This article has a correction. Please see:

Summary

Most patients with leukemia or disseminated cancer are treated with cytotoxic chemotherapeutic drugs that arrest malignant cell proliferation. These compounds may also kill cancer cells, but why this happens in some types of cancers but not others has not been clear. On page 1129 of this issue, Ni Chonghaile et al. (1) indicate a critical role for mitochondria-initiated cell death mechanisms controlled by Bcl-2 family proteins in dictating whether patients respond to cytotoxic anticancer drugs.